Clinical Trial Update: Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial

View source ↗

Summary

Three-year follow-up results from participants in a prior Lambda (BMS-914143) chronic hepatitis C trial, summarizing long-term safety and outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Lambda (BMS-914143) (BMS-914143)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C | Status: COMPLETED